Tocilizumab Spirig HC 80 mg/4 ml
Tocilizumab Spirig HC 80 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 69925. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 May 2025 and the authorisation is limited until 20 May 2030. ATC code L04AC07 places the medicine in the group Immunosuppressants.
| Authorisation number | 69925 |
|---|---|
| Name | Tocilizumab Spirig HC 80 mg/4 ml |
| Full name | Tocilizumab Spirig HC 80 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AC07 |
| First authorisation | 21 May 2025 |
| Authorisation validity | 20 May 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tocilizumab Spirig HC 80 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 21 May 2025 |
| 2 | Tocilizumab Spirig HC 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 21 May 2025 |
| 3 | Tocilizumab Spirig HC 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 21 May 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 7 | 1 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
| 8 | 4 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
| 9 | 1 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
| 10 | 4 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
| 11 | 1 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
| 12 | 4 | Durchstechflasche(n) | L04AC07 | 07.15.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tocilizumab Spirig HC 80 mg/4 ml authorised in Switzerland?
Yes. Tocilizumab Spirig HC 80 mg/4 ml is authorised by Swissmedic under authorisation number 69925, data as of 01 September 2026. The authorisation is limited until 20 May 2030.
Which dispensing category does Tocilizumab Spirig HC 80 mg/4 ml have?
Tocilizumab Spirig HC 80 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tocilizumab Spirig HC 80 mg/4 ml?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.